Leukaemia inhibitory factor or Oncostatin M induction of Swiss 3T3 cells does not require mevalonic acid synthesis nor protein isoprenylation to initiate DNA replication
Leukaemia inhibitory factor (LIF) or Oncostatin M (OSM), both mitogens for Swiss mouse 3T3 cells, triggers initiation of DNA synthesis without the requirement for mevalonic acid. Thus, Lovastatin (LOV), an inhibitor of the hydroxy methylglutaryl CoA (HMGCoA) reductase, does not block LIF or OSM indu...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Academic Press Inc.
2004
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 12548caa a22011897a 4500 | ||
|---|---|---|---|
| 001 | PAPER-21314 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205245.0 | ||
| 008 | 190411s2004 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0346728754 | |
| 024 | 7 | |2 cas |a 3 hydroxy 3 methylglutaryl coenzyme A, 1553-55-5; DNA, 9007-49-2; mevalonic acid, 150-97-0; mevinolin, 75330-75-5; oncostatin M, 106956-32-5 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a BBRCA | ||
| 100 | 1 | |a Sauane, M. | |
| 245 | 1 | 0 | |a Leukaemia inhibitory factor or Oncostatin M induction of Swiss 3T3 cells does not require mevalonic acid synthesis nor protein isoprenylation to initiate DNA replication |
| 260 | |b Academic Press Inc. |c 2004 | ||
| 270 | 1 | 0 | |m Jimenez De Asua, L.; Inst. Invest. Bioquimicas Fund. I., Av. Patricias Argentinas 435, (1405) Buenos Aires, Argentina; email: ljimeneza@leloir.org.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Jimenez De Asua, L., Richmond, K.M.C., Otto, A.M., Two growth factors and two hormones regulate the initiation of DNA synthesis in cultured mouse cells through different pathways of events (1981) Proc. Natl. Acad. Sci. USA, 78, pp. 1004-1008 | ||
| 504 | |a Rozengurt, E., Early mitogenic signals (1986) Science, 234, pp. 161-166 | ||
| 504 | |a Pardee, A.B., G1 events and regulations of cell proliferation (1989) Science, 246, pp. 603-608 | ||
| 504 | |a Berridge, M.J., Inositol triphosphate and calcium signalling (1993) Nature, 361, pp. 315-325 | ||
| 504 | |a Goldstein, J.L., Brown, M.S., Regulation of the mevalonate pathway (1990) Nature, 343, pp. 425-430 | ||
| 504 | |a Zang, F., Casey, P., Protein prenylation: Molecular mechanisms and functional consequences (1996) Ann. Rev. Biochem., 65, pp. 241-269 | ||
| 504 | |a Chen, H.W., Heininger, H.J., Kandusch, A.A., Relationship between sterol synthesis in phytohemagglutinin-stimulated mouse lymphocytes (1975) Proc. Natl. Acad. Sci. USA, 86, pp. 8323-8327 | ||
| 504 | |a Larsson, O., Zetterberg, A., Effects of 25-hydroxycholesterol, cholesterol and isoprenoid derivatives on the G1 progression in Swiss 3T3 cells (1986) J. Cell. Physiol., 129, pp. 94-102 | ||
| 504 | |a Larsson, O., Barrios, C., Lotham, C., Ruiz, J., Zetterberg, A., Zickert, P., Wedje, J., Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation by Simian Virus 40 (1989) Cancer Res., 49, pp. 5605-5610 | ||
| 504 | |a Larsson, O., Johansson, B.A., Mevalonic acid products as mediators of cell proliferation in simian virus 40-transformed 3T3 cell (1987) Cancer Res., 47, pp. 4825-4829 | ||
| 504 | |a Brown, M.S., Faust, J.R., Goldstein, J.L., Kaneko, I., Endo, A., Induction of hydroxyl 3- hydroxy 3 methyl glutaryl coenzyme a reductase activity in human fibroblasts incubated with compactine (ML236B), competitive inhibitor of the reductase (1978) J. Biol. Chem., 253, pp. 1121-1128 | ||
| 504 | |a Alberts, A.W., Chen, J., Kuran, G., Hunt, V., Huff, J., Hoffman, C., Rothrock, J., Springer, J., Mevinolin a highly potent competitive inhibitor of HMG-CoA reductase and a cholesterol-lowering agent (1980) Proc. Natl. Acad. Sci. USA, 77, pp. 3857-3861 | ||
| 504 | |a Habenicht, A.J.R., Glomset, J.A., Ross, R., Relation of cholesterol and mevalonic acid to the cell cycle in smooth and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor (1980) J. Biol. Chem., 255, pp. 5134-5140 | ||
| 504 | |a Fairbanks, K.P., Witte, L.D., Goodman, D.S., Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor (1984) J. Biol. Chem., 259, pp. 1546-1551 | ||
| 504 | |a Quesney-Hunneus, V., Galik, H.A., Siperstein, M.D., Ericson, S.K., Spencer, T.A., Nelson, J.A., The dual role of mevalonate in the cycle (1983) J. Biol. Chem., 258, pp. 378-385 | ||
| 504 | |a Fairbanks, K.P., Barbu, V.D., Whitte, L.D., Weinstein, I.B., Goodman, D.S., Effects of mevinolin and mevalonate on cell growth in several transformed cells lines (1986) J. Cell. Physiol., 127, pp. 216-222 | ||
| 504 | |a Casey, P.J., Solski, P.A., Der, C.J., Buss, J.E., P21ras is modified by a farnesyl isoprenoid (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 8323-8327 | ||
| 504 | |a Beck, L.A., Hosick, T.J., Sineski, M., Incorporation of a product of mevalonic acid metabolite into proteins of chinese hamsters ovary cell nuclei (1988) J. Cell Biol., 107, pp. 1307-1316 | ||
| 504 | |a Magge, T., Newman, C., The role of lipid anchors for small G proteins in membrane trafficking (1992) Trends Cell Biol., 2, pp. 318-323 | ||
| 504 | |a Maltese, W.A., Posttranslational modifications of proteins by isoprenoids in mammalian cells (1990) FASEB J., 4, pp. 3319-3328 | ||
| 504 | |a Jacobisiak, J., Bruno, S., Sierski, J.S., Darzynkiewicz, Z., Cell cycle-specific effects of lovastatin (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 3628-3632 | ||
| 504 | |a Ortiz, M.B., Goin, M., Gomez De Alzaga, M.B., Hammarstrom, S., Jimenez De Asua, L., Mevalonate dependency of the early cell cycle mitogenic response to epidermal growth factor and prostaglandin F2α in Swiss 3T3 Cells (1995) J. Cell. Physiol., 162, pp. 139-146 | ||
| 504 | |a Hilton, D.J., LIF Lots of interesting functions (1992) Trends Biochem. Sci., 17, pp. 72-76 | ||
| 504 | |a Yoshimura, A., Ichihara, M., Kiniyo, I., Moriyama, M., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Miyayima, A., Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT 5 pathway (1996) EMBO J., 15, pp. 1055-1063 | ||
| 504 | |a Schere-Levy, C., Sauane, M., Rudland, P.S., Jimenez De Asua, L., Leukaemia inhibitory factor (LIF) induces mitogenesis in Swiss mouse 3T3 cells and selects enhancement via a variety of signalling events (1997) Biochem. Biophys. Res. Commun., 236, pp. 814-818 | ||
| 504 | |a Todaro, G., Green, H., Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines (1963) J. Cell Biol., 17, pp. 289-313 | ||
| 504 | |a Goin, M., Pignataro, O., Jimenez De Asua, L., Early cell diacylglycerol (DAG) content and protein kinase C (PKC) activity enhancement potentiates prostaglandin F2α (PGF 2α) induced mitogenesis in Swiss 3T3 cells (1993) FEBS Lett., 316, pp. 68-72 | ||
| 504 | |a Keyomarsi, K., Sandoval, L., Band, V., Pardee, A.B., Synchronization of tumor and normal cells from G1 to multiple cell cycle by lovastatin (1991) Cancer Res., 51, pp. 3602-3609 | ||
| 504 | |a Gomez De Alzaga, M.B., Goin, M., Ortiz, M.B., Jimenez De Asua, L., Transforming growth factor β (TG β) , insulin, prostaglandin E1 (PGE1) enhance prostaglandin F2α (PGF2α) mitogenic action in Swiss 3T3 cells via separate events (1994) FEBS Lett., 356, pp. 21-24 | ||
| 504 | |a Otto, A.M., Nilsen Hamilton, M., Boss, B., Ulrich, M.O., Jimenez De Asua, L., Prostaglandin E1 and E2 interact with prostaglandin F2α to regulate the initiation of DNA replication and cell division (1982) Proc. Natl. Acad. Sci. USA, 79, pp. 4992-4996 | ||
| 504 | |a Evans, D.B., Gerber, B., Feyen, J.H.M., Recombinant human leukaemia inhibitory factor is mitogenic for human bone-derived osteoblast-like cells (1994) Biochem. Biophys. Res. Commun., 199, pp. 220-226 | ||
| 504 | |a Jay, P.R., Centrella, M., Lorenzo, J., Bruce, A.G., Horowitz, M.C., Oncostatin M a new bone active cytokine that activates osteoblasts and inhibits bone reabsorption (1996) Endocrinology, 137, pp. 1147-1150 | ||
| 504 | |a Kurek, J., Bower, J., Romanella, M., Austin, A., Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse (1996) Neurosci. Lett., 212, pp. 167-170 | ||
| 504 | |a Doyle, J.W., Kanducth, A.A., Requirement for mevalonate in cycling cells: Quantitative and temporal aspects (1988) J. Cell. Physiol., 137, pp. 133-140 | ||
| 504 | |a Declue, J.E., Vass, W.C., Papageorge, A.G., Lowry, D.R., Williumsem, B.M., Inhibition of cell growth independent of ras function (1991) Cancer Res., 51, pp. 712-717 | ||
| 504 | |a Chun-Li, Y., Men- Hwei, T.S.A.I., Stacey, D.W., Cellular ras activity and phospholipid metabolism (1998) Cell, 52, pp. 63-71 | ||
| 504 | |a Johnson, J.A., Nathanson, N.M., Differential requirements for p21 ras and protein kinase C expression by nerve growth factor and neurokines (1994) J. Biol. Chem., 269, pp. 18856-18863 | ||
| 504 | |a Van Puijenbroek, A.A.F.L., Van Der Saag, P.T., Coffer, P.J., Cytokine signal transduction in P19 embryonal carcinoma cells: Regulation of STAT3-mediated transactivation occurs independently of p21 ras-ERK signalling (1999) Exp. Cell Res., 251, pp. 465-476 | ||
| 520 | 3 | |a Leukaemia inhibitory factor (LIF) or Oncostatin M (OSM), both mitogens for Swiss mouse 3T3 cells, triggers initiation of DNA synthesis without the requirement for mevalonic acid. Thus, Lovastatin (LOV), an inhibitor of the hydroxy methylglutaryl CoA (HMGCoA) reductase, does not block LIF or OSM induced DNA replication and cell multiplication. In contrast, increasing concentrations of LOV from 1 to 60 μM block the mitogenic action of PGF 2α by decreasing the number of cells capable of entering S-phase and dividing. This inhibition by LOV can be reversed by addition of mevanolactone (MEV), an analogue of mevalonic acid. Thus, LIF or OSM triggers initiation of DNA replication independently of mevalonic acid synthesis and therefore without the involvement of isoprenylation of various signalling proteins. © 2003 Elsevier Inc. All rights reserved. |l eng | |
| 536 | |a Detalles de la financiación: Association for International Cancer Research, AICR | ||
| 536 | |a Detalles de la financiación: Cancer and Polio Research Fund | ||
| 536 | |a Detalles de la financiación: University of Liverpool | ||
| 536 | |a Detalles de la financiación: L.J. de A. was a Royal Society Visiting Professor (London, UK) at the Molecular Medicine Group in the School Biological Sciences, University of Liverpool, UK. We thank Ms Liz Shannon of Becton and Dickinson for the generous gift of tissue culture material and Dr. Neil Nathanson for providing useful information. This study was supported by grants from the Association for International Cancer Research, No. 099–018 Scotland, UK, and The Cancer and Polio Research Fund (Liverpool) awarded to L.J. de A. and P.S.R., respectively. M.S. was a Fellow and O.C. and L.J.A. are investigators of the National Research Council (CONICET) of Argentina. | ||
| 593 | |a Inst. Invest. Bioquimicas Fund. I., Av. Patricias Argentinas 435, (1405) Buenos Aires, Argentina | ||
| 593 | |a Lab. de Fisiol. y Biol. Molecular, F.C.E.N, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina | ||
| 593 | |a School of Biological Sciences, University of Liverpool, Liverpool L69 7ZB, United Kingdom | ||
| 690 | 1 | 0 | |a DNA REPLICATION |
| 690 | 1 | 0 | |a INSULIN |
| 690 | 1 | 0 | |a LEUKAEMIA INHIBITORY FACTOR |
| 690 | 1 | 0 | |a MEVALONIC ACID |
| 690 | 1 | 0 | |a ONCOSTATIN M |
| 690 | 1 | 0 | |a 3 HYDROXY 3 METHYLGLUTARYL COENZYME A |
| 690 | 1 | 0 | |a DNA |
| 690 | 1 | 0 | |a LEUKEMIA INHIBITORY FACTOR |
| 690 | 1 | 0 | |a MEVALONIC ACID |
| 690 | 1 | 0 | |a MEVINOLIN |
| 690 | 1 | 0 | |a ONCOSTATIN M |
| 690 | 1 | 0 | |a ANIMAL CELL |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CELL CYCLE S PHASE |
| 690 | 1 | 0 | |a CELL DIVISION |
| 690 | 1 | 0 | |a CELL STRAIN 3T3 |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a DNA REPLICATION |
| 690 | 1 | 0 | |a LEUKEMIA |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROTEIN INDUCTION |
| 690 | 1 | 0 | |a PROTEIN PROCESSING |
| 690 | 1 | 0 | |a SIGNAL TRANSDUCTION |
| 700 | 1 | |a Coso, O.A. | |
| 700 | 1 | |a Giulianelli, S. | |
| 700 | 1 | |a Giráldez, A.N. | |
| 700 | 1 | |a Rudland, P.S. | |
| 700 | 1 | |a Jimenez De Asua, L. | |
| 773 | 0 | |d Academic Press Inc., 2004 |g v. 313 |h pp. 926-930 |k n. 4 |p Biochem. Biophys. Res. Commun. |x 0006291X |w (AR-BaUEN)CENRE-905 |t Biochemical and Biophysical Research Communications | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0346728754&doi=10.1016%2fj.bbrc.2003.11.182&partnerID=40&md5=56822ec7c46d584d5d3528031ad08e7a |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bbrc.2003.11.182 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_0006291X_v313_n4_p926_Sauane |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0006291X_v313_n4_p926_Sauane |y Registro en la Biblioteca Digital |
| 961 | |a paper_0006291X_v313_n4_p926_Sauane |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 963 | |a VARI | ||
| 999 | |c 82267 | ||